Search Results for “” – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Change patient management Highlighted Clinical outcomes Safety

4 Publications found

Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial.

b

Circulation. Cardiovascular interventions

June 1, 2018

p ACT Guided Heparinization

c Change patient management Clinical outcomes Highlighted Observational Safety
Activated clotting time and outcomes during percutaneous coronary intervention for non-ST-segment-elevation myocardial infarction: insights from the FUTURA/OASIS-8 Trial.

b

Circulation. Cardiovascular interventions

April 1, 2015

p ACT Guided Heparinization

c Change patient management Clinical outcomes Highlighted RCT Safety
Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.

b

The Annals of pharmacotherapy

March 1, 2015

p ACT Guided Heparinization

c Change patient management Clinical outcomes Highlighted Observational Safety
Impact of international normalized ratio and activated clotting time on unfractionated heparin dosing during ablation of atrial fibrillation.

b

Circulation. Arrhythmia and electrophysiology

June 1, 2013

p ACT Guided Heparinization

c Change patient management Clinical outcomes Highlighted Observational Safety